Company news
Intelligent Bio Solutions Inc. news in 2023
Intelligent Bio Solutions Inc.'s news releases, calls and decks from 2023, newest first.
Intelligent Bio Solutions Receives NATA Accreditation for its Revolutionary Fingerprint Sweat Drug Screening System
December 18, 2023
Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
November 7, 2023
Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
October 23, 2023
Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
October 4, 2023
Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
October 3, 2023
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
October 1, 2023
Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
September 26, 2023
Intelligent Bio Solutions Successfully Debuts Intelligent Fingerprinting Drug Screening Solution at the 2023 Workplace Health & Safety Show in Sydney, Australia
September 20, 2023
Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test
September 7, 2023
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights
August 23, 2023
Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia
July 31, 2023
Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
July 5, 2023
Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
June 27, 2023
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
June 19, 2023
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Third Quarter Financial Results and Operational Highlights
May 10, 2023
Intelligent Bio Solutions Secures UK Patent for Intelligent Fingerprinting DSR-Plus Cartridge Reader
April 17, 2023
Intelligent Bio Solutions Inc. Selects HASTA Laboratory as Drug Testing Specialist in Australia
March 12, 2023
Intelligent Bio Solutions Inc. Announces Closing of $2.55 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares and Warrants
March 9, 2023
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
March 7, 2023
Intelligent Bio Solutions Inc. Announces Proposed Public Offering
March 6, 2023
Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Listing Requirement
February 28, 2023
Intelligent Bio Solutions Inc. files FDA 513(g) regulatory submission for Intelligent Fingerprinting Drug Screening Cartridge
February 15, 2023
Intelligent Bio Solutions Inc. Reports Fiscal 2023 Second Quarter Financial Results and Operational Highlights
February 13, 2023
Intelligent Bio Solutions Inc. Announces Leading Food Industry Logistics Provider to Implement Fingerprint Drug Testing, Replacing Urine Testing
February 6, 2023
Intelligent Bio Solutions Inc. Announces Global Garden Equipment Manufacturer to Introduce Intelligent Fingerprinting Drug Tests
January 30, 2023
Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development
January 22, 2023